Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline data

Multiple Sclerosis : Clinical and Laboratory Research
J A CohenACT Investigators

Abstract

To review the rationale, design and baseline data of the Avonex Combination Trial (ACT), an investigator-run study of intramuscular interferon beta-1a (IM IFNbeta-1a) combined with methotrexate (MTX) and/or IV methylprednisolone (IVMP) in relapsing-remitting multiple sclerosis (RRMS) patients with continued disease activity on IM IFNbeta-1a monotherapy. Eligibility criteria included RRMS, Expanded Disability Status Scale score 0-5.5, and >or=1 relapse or gadolinium-enhancing MRI lesion in the prior year while on IM IFNbeta-1a monotherapy. Subjects continued IFNbeta-1a 30 mcg IM weekly and were randomized in a 2 x 2 factorial design to adjunctive weekly placebo or MTX 20 mg PO, with or without IVMP 1,000 mg/day for three days every other month. ACT was industry-supported, and collaboratively designed and governed by an Investigator Steering Committee with independent Advisory and Data Safety Monitoring Committees. Study operations, MRI analysis and aggregated data were managed by the Cleveland Clinic MS Academic Coordinating Center. In total 313 subjects were enrolled with clinical and MRI characteristics typical of RRMS. Most subjects (86.9%) qualified with a clinical relapse, with or without an enhancing MRI lesion, in the pre...Continue Reading

References

Jul 1, 1988·Journal of the American Academy of Dermatology·H H RoenigkG D Weinstein
Feb 1, 1988·Arthritis and Rheumatism·M E WeinblattJ S Coblyn
Jul 1, 1987·Cleveland Clinic Journal of Medicine·W S WilkeA M Segal
Mar 28, 1985·The New England Journal of Medicine·M E WeinblattD E Trentham
Aug 1, 1994·Acta Neurologica Scandinavica·S T FrequinO R Hommes
Nov 1, 1993·Journal of Neurology, Neurosurgery, and Psychiatry·R D CurrierE F Meydrech
Nov 1, 1995·British Journal of Rheumatology·D M SandovalS L Morgan
Nov 1, 1995·Cleveland Clinic Journal of Medicine·J A Flynn, D B Hellmann
Jan 1, 1995·Duodecim; lääketieteellinen aikakauskirja·M PaneliusJ Ruutiainen
Apr 26, 2001·Multiple Sclerosis : Clinical and Laboratory Research·N D RichertJ A Frank
Nov 27, 2002·Neurology·M ClanetUNKNOWN European IFNbeta-1a (Avonex) Dose-Comparison Study Investigators
Dec 31, 2002·Lancet·Hans-Peter HartungUNKNOWN Mitoxantrone in Multiple Sclerosis Study Group (MIMS)
Dec 21, 2004·Journal of the Neurological Sciences·Alessandra SolariEnrico Montanari
Sep 15, 2005·Neurology·H KrapfUNKNOWN MIMS Study Group
Mar 3, 2006·The New England Journal of Medicine·Chris H PolmanUNKNOWN AFFIRM Investigators
Mar 3, 2006·The New England Journal of Medicine·Richard A RudickUNKNOWN SENTINEL Investigators
May 1, 2007·Multiple Sclerosis : Clinical and Laboratory Research·R J FoxR A Rudick
Jan 1, 1995·IEEE Transactions on Image Processing : a Publication of the IEEE Signal Processing Society·P Santago, H D Gage

❮ Previous
Next ❯

Citations

Mar 28, 2009·Journal of Neurology·Andrew ChanNicolas von Ahsen
Mar 28, 2009·Journal of Neurology·Hayretin Tumani
Aug 15, 2009·Current Medical Research and Opinion·Mark S FreedmanBianca Weinstock-Guttman
Jul 4, 2012·Multiple Sclerosis and Related Disorders·Jw LindseyUNKNOWN the CombiRx Investigators Group
Nov 30, 2010·Journal of Neuroimmunology·Ron Milo, Hillel Panitch
Apr 7, 2010·Clinical Neurology and Neurosurgery·Reza Vosoughi, Mark S Freedman
Sep 6, 2008·Acta Neurologica Scandinavica·M BraitchC S Constantinescu
Jul 14, 2010·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Jochen C UlzheimerHeinz Wiendl
Jul 29, 2008·Annals of Neurology·Elizabeth FisherRichard A Rudick
Dec 22, 2015·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·Lael Anne StoneHenry McFarland
Sep 5, 2008·American Journal of Physiology. Cell Physiology·Paul R StabachJon S Morrow
Jan 24, 2021·Nature Reviews. Neurology·Fernando DangondMarco Salvetti

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.